A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

Haematologica. 2022 Sep 1;107(9):2244-2248. doi: 10.3324/haematol.2022.281068.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • COVID-19*
  • Humans
  • Thrombosis* / diagnosis
  • Thrombosis* / etiology
  • Thrombosis* / prevention & control
  • Venous Thromboembolism* / etiology
  • Venous Thromboembolism* / genetics

Substances

  • Anticoagulants

Grants and funding

Funding: This work was funded by the Regional Government of Catalonia under grants SGR_1736 (to JMS), the CERCA Program, and the nonprofit association Activa´TT por la Salud.